お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は慢性血栓塞栓性肺高血圧症市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは慢性血栓塞栓性肺高血圧症の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の慢性血栓塞栓性肺高血圧症市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは慢性血栓塞栓性肺高血圧症のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に慢性血栓塞栓性肺高血圧症市場を分類しています。本研究に含まれる主な企業は：Bayer、Johnson & Johnson、Nippon Shinyaku、GlaxoSmithKline、Sun Pharmaceutical Industries、Scipharm SaRL、Promedica International、Medical Research Network、Gilead Sciences、Daiichi Sankyo

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Transthoracic Echocardiogram (TTE)
    Ventilation-Perfusion (V/Q) Scan
    Pulmonary Angiography
    Heart Catheterization
    Computed Tomography (CT) Pulmonary Angiography
    Others

用途別の市場セグメント：
    Hospitals
    Ambulatory Surgical Centers
    Others

本レポートの詳細内容
世界の慢性血栓塞栓性肺高血圧症市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、慢性血栓塞栓性肺高血圧症タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の慢性血栓塞栓性肺高血圧症収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の慢性血栓塞栓性肺高血圧症市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、慢性血栓塞栓性肺高血圧症市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

慢性血栓塞栓性肺高血圧症のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：慢性血栓塞栓性肺高血圧症のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：慢性血栓塞栓性肺高血圧症の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章慢性血栓塞栓性肺高血圧症企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：慢性血栓塞栓性肺高血圧症の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：慢性血栓塞栓性肺高血圧症の主要企業の概要を提供し、製品の説明と仕様、慢性血栓塞栓性肺高血圧症の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical condition in which pulmonary vascular resistance increases giving rise to pulmonary hypertension and progressive heart failure. According to World Health Organization (WHO), approximately 0.15% to 0.55% of the patients suffering with acute pulmonary embolism develop chronic thromboembolic pulmonary hypertension. Due to non-specific symptoms observed in chronic thromboembolic pulmonary hypertension its diagnosis is complex. However, some of the prominent symptoms of chronic thromboembolic pulmonary hypertension are chest discomfort, breathlessness and fatigue. Chronic thromboembolic pulmonary hypertension market can be segmented on the basis of types of diagnosis such as transthoracic echocardiogram (TTE), ventilation-perfusion (V/Q) scan, pulmonary angiography, heart catheterization, computed tomography (CT) pulmonary angiography and other pulmonary function tests.
Market Analysis and Insights: Global Chronic Thromboembolic Pulmonary Hypertension Market
The global Chronic Thromboembolic Pulmonary Hypertension market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Chronic Thromboembolic Pulmonary Hypertension market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Chronic Thromboembolic Pulmonary Hypertension, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Chronic Thromboembolic Pulmonary Hypertension, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Chronic Thromboembolic Pulmonary Hypertension revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Chronic Thromboembolic Pulmonary Hypertension market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Chronic Thromboembolic Pulmonary Hypertension revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer, Johnson & Johnson, Nippon Shinyaku, GlaxoSmithKline, Sun Pharmaceutical Industries, Scipharm SaRL, Promedica International, Medical Research Network and Gilead Sciences, etc.

Market Segmentation
By Company
    Bayer
    Johnson & Johnson
    Nippon Shinyaku
    GlaxoSmithKline
    Sun Pharmaceutical Industries
    Scipharm SaRL
    Promedica International
    Medical Research Network
    Gilead Sciences
    Daiichi Sankyo

Segment by Type
    Transthoracic Echocardiogram (TTE)
    Ventilation-Perfusion (V/Q) Scan
    Pulmonary Angiography
    Heart Catheterization
    Computed Tomography (CT) Pulmonary Angiography
    Others

Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Chronic Thromboembolic Pulmonary Hypertension in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Thromboembolic Pulmonary Hypertension companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chronic Thromboembolic Pulmonary Hypertension revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Transthoracic Echocardiogram (TTE)
    Table 3. Key Players of Ventilation-Perfusion (V/Q) Scan
    Table 4. Key Players of Pulmonary Angiography
    Table 5. Key Players of Heart Catheterization
    Table 6. Key Players of Computed Tomography (CT) Pulmonary Angiography
    Table 7. Key Players of Others
    Table 8. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2019-2024)
    Table 12. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2025-2030)
    Table 14. Chronic Thromboembolic Pulmonary Hypertension Market Trends
    Table 15. Chronic Thromboembolic Pulmonary Hypertension Market Drivers
    Table 16. Chronic Thromboembolic Pulmonary Hypertension Market Challenges
    Table 17. Chronic Thromboembolic Pulmonary Hypertension Market Restraints
    Table 18. Global Chronic Thromboembolic Pulmonary Hypertension Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Share by Players (2019-2024)
    Table 20. Global Top Chronic Thromboembolic Pulmonary Hypertension by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Thromboembolic Pulmonary Hypertension as of 2023)
    Table 21. Global Chronic Thromboembolic Pulmonary Hypertension Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Chronic Thromboembolic Pulmonary Hypertension Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Chronic Thromboembolic Pulmonary Hypertension, Headquarters and Area Served
    Table 24. Global Key Players of Chronic Thromboembolic Pulmonary Hypertension, Product and Application
    Table 25. Global Key Players of Chronic Thromboembolic Pulmonary Hypertension, Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Type (2019-2024)
    Table 29. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Type (2025-2030)
    Table 31. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Share by Application (2019-2024)
    Table 33. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Share by Application (2025-2030)
    Table 35. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Chronic Thromboembolic Pulmonary Hypertension Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Chronic Thromboembolic Pulmonary Hypertension Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Chronic Thromboembolic Pulmonary Hypertension Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030) & (US$ Million)
    Table 67. Bayer Company Details
    Table 68. Bayer Business Overview
    Table 69. Bayer Chronic Thromboembolic Pulmonary Hypertension Product
    Table 70. Bayer Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 71. Bayer Recent Developments
    Table 72. Johnson & Johnson Company Details
    Table 73. Johnson & Johnson Business Overview
    Table 74. Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Product
    Table 75. Johnson & Johnson Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 76. Johnson & Johnson Recent Developments
    Table 77. Nippon Shinyaku Company Details
    Table 78. Nippon Shinyaku Business Overview
    Table 79. Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Product
    Table 80. Nippon Shinyaku Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 81. Nippon Shinyaku Recent Developments
    Table 82. GlaxoSmithKline Company Details
    Table 83. GlaxoSmithKline Business Overview
    Table 84. GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Product
    Table 85. GlaxoSmithKline Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 86. GlaxoSmithKline Recent Developments
    Table 87. Sun Pharmaceutical Industries Company Details
    Table 88. Sun Pharmaceutical Industries Business Overview
    Table 89. Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Product
    Table 90. Sun Pharmaceutical Industries Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 91. Sun Pharmaceutical Industries Recent Developments
    Table 92. Scipharm SaRL Company Details
    Table 93. Scipharm SaRL Business Overview
    Table 94. Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Product
    Table 95. Scipharm SaRL Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 96. Scipharm SaRL Recent Developments
    Table 97. Promedica International Company Details
    Table 98. Promedica International Business Overview
    Table 99. Promedica International Chronic Thromboembolic Pulmonary Hypertension Product
    Table 100. Promedica International Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 101. Promedica International Recent Developments
    Table 102. Medical Research Network Company Details
    Table 103. Medical Research Network Business Overview
    Table 104. Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Product
    Table 105. Medical Research Network Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 106. Medical Research Network Recent Developments
    Table 107. Gilead Sciences Company Details
    Table 108. Gilead Sciences Business Overview
    Table 109. Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Product
    Table 110. Gilead Sciences Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 111. Gilead Sciences Recent Developments
    Table 112. Daiichi Sankyo Company Details
    Table 113. Daiichi Sankyo Business Overview
    Table 114. Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Product
    Table 115. Daiichi Sankyo Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)
    Table 116. Daiichi Sankyo Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Type: 2023 VS 2030
    Figure 3. Transthoracic Echocardiogram (TTE) Features
    Figure 4. Ventilation-Perfusion (V/Q) Scan Features
    Figure 5. Pulmonary Angiography Features
    Figure 6. Heart Catheterization Features
    Figure 7. Computed Tomography (CT) Pulmonary Angiography Features
    Figure 8. Others Features
    Figure 9. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Application: 2023 VS 2030
    Figure 11. Hospitals Case Studies
    Figure 12. Ambulatory Surgical Centers Case Studies
    Figure 13. Others Case Studies
    Figure 14. Chronic Thromboembolic Pulmonary Hypertension Report Years Considered
    Figure 15. Global Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Chronic Thromboembolic Pulmonary Hypertension Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Region: 2023 VS 2030
    Figure 18. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Players in 2023
    Figure 19. Global Top Chronic Thromboembolic Pulmonary Hypertension Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Thromboembolic Pulmonary Hypertension as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Chronic Thromboembolic Pulmonary Hypertension Revenue in 2023
    Figure 21. North America Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Chronic Thromboembolic Pulmonary Hypertension Market Share by Type (2019-2030)
    Figure 23. North America Chronic Thromboembolic Pulmonary Hypertension Market Share by Application (2019-2030)
    Figure 24. North America Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2019-2030)
    Figure 25. United States Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Chronic Thromboembolic Pulmonary Hypertension Market Share by Type (2019-2030)
    Figure 29. Europe Chronic Thromboembolic Pulmonary Hypertension Market Share by Application (2019-2030)
    Figure 30. Europe Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2019-2030)
    Figure 31. Germany Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Chronic Thromboembolic Pulmonary Hypertension Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Chronic Thromboembolic Pulmonary Hypertension Market Share by Type (2019-2030)
    Figure 39. China Chronic Thromboembolic Pulmonary Hypertension Market Share by Application (2019-2030)
    Figure 40. Asia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Chronic Thromboembolic Pulmonary Hypertension Market Share by Type (2019-2030)
    Figure 42. Asia Chronic Thromboembolic Pulmonary Hypertension Market Share by Application (2019-2030)
    Figure 43. Asia Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2019-2030)
    Figure 44. Japan Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2019-2030)
    Figure 54. Brazil Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Bayer Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 61. Johnson & Johnson Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 62. Nippon Shinyaku Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 63. GlaxoSmithKline Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 64. Sun Pharmaceutical Industries Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 65. Scipharm SaRL Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 66. Promedica International Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 67. Medical Research Network Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 68. Gilead Sciences Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 69. Daiichi Sankyo Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed